Forefront Tech Holdings Acquisition Corp. — Form 10-Q Summary
Reporting period: Quarter ended September 30, 2026; filed November 10, 2026. The company is a Cayman Islands blank-check company (SPAC), has not selected a business-combination target, and has not begun operations or generated operating revenue. It expects to focus on technology but may pursue targets in any industry or geography.
Financial results and position
| Metric | Three months ended September 30, 2026 | Nine months ended September 30, 2026 |
|---|---|---|
| Operating revenue | $0 | $0 |
| General and administrative expenses | $168,948 | $408,610 |
| Trust investment interest income | $914,285 | $1,474,693 |
| Change in over-allotment option fair value | $0 | $78,900 income |
| Net income | $745,337 | $1,144,983 |
| Basic and diluted earnings per share, Class A and B | $0.05 each | $0.13 each |
- Assets and liquidity at September 30: Total assets were $102.84 million, including $101.77 million in the Trust Account and $885,826 in cash outside the Trust. Reported working capital was $934,725.
- Trust and redeemable shares: The 10 million public Class A shares were classified as temporary equity at a redemption value of $10.18 per share, totaling $101.77 million. Trust assets are held in money market funds invested primarily in U.S. Treasury securities.
- Cash flow, nine months: Operating activities used $513,938; investing activities used $100.30 million, principally funding the Trust Account; financing activities provided $101.70 million. Cash increased from zero to $885,826.
- Debt and liabilities: No working-capital loans were outstanding, and the related-party promissory note had been repaid. Total liabilities were $3.10 million, principally a $3.0 million deferred underwriting fee payable only upon completion of a business combination; deferred legal fees were $17,020.
- Margins: Operating and gross margins are not meaningful because the SPAC has no operating revenue. Net income primarily reflects interest earned on trust assets, not operating performance.
Changes, outlook, and risks
- The IPO closed May 1, 2026, raising $100 million from 10 million public units; a concurrent private placement raised $3.7 million. A total of $100.3 million was placed in trust. The filing provides no prior-year comparable operating results; the balance sheet compares with December 31, 2025, when trust investments and cash were nil.
- The over-allotment option expired unexercised on June 15, 2026, and 500,000 founder shares were forfeited. At September 30, 3,333,333 Class B shares were outstanding. The company also had 370,000 non-redeemable Class A shares outstanding.
- Management says available funds should cover working-capital needs for one year from issuance of the financial statements, but warns that higher-than-expected search, due-diligence, or transaction costs could leave insufficient funds outside the trust. Management’s expectation to complete a business combination is not assured.
- The company must complete a business combination by November 1, 2027, 18 months after the IPO, or redeem public shares and wind up. The filing says this mandatory liquidation date raises substantial doubt about the company’s ability to continue as a going concern; the financial statements include no adjustments for the outcome.
- A target must generally have fair market value of at least 80% of the trust balance, subject to the filing’s stated exclusions, and the post-combination company must acquire control. Public shareholders may redeem shares in connection with a transaction or liquidation. The $3 million deferred underwriting fee is payable upon a completed transaction.
- Risks include the possibility of failing to complete a transaction, claims against trust assets, geopolitical and market disruption, and uncertainty over the sponsor’s ability to meet its trust indemnity obligations. The sponsor has not reserved funds for that indemnity, and the company says it cannot assure the sponsor could satisfy it.
- No legal proceedings, material risk-factor changes, or subsequent events requiring disclosure were reported. Management concluded disclosure controls were effective at quarter-end; no material change in internal control over financial reporting was reported.
Important facts for investors to verify
- Whether management identifies a target and can complete a transaction before the November 1, 2027 deadline, including the transaction’s financing, redemption levels, and dilution.
- Trust balance, per-share redemption value, permitted withdrawals for taxes, and any creditor claims or other amounts that could affect public-shareholder recoveries.
- Cash available outside the trust and expected spending on target search and due diligence; the filing’s liquidity assessment depends on costs staying within estimates.
- Terms and payment of the deferred underwriting fee and deferred legal fees upon a business combination.
- Potential dilution and exercise terms for 5 million public warrants and 185,000 private placement warrants, each whole warrant exercisable at $11.50 per share after a business combination, subject to stated conditions.